Showing results (1571-1580 of 3,100) with videos related to
Sort By:
Pageof 310
Expert Review of Anticancer Therapy|November 15, 2013
Economic evaluation of sipuleucel-T immunotherapy in castration-resistant prostate cancerPrzemysław Holko, Paweł KawalecExpert Review of Anticancer Therapy|October 16, 2013
Do theoretical potential and advanced technology justify the use of high-dose rate brachytherapy as monotherapy for prostate cancer?Nicholas G Zaorsky, Laura A Doyle, Mark D Hurwitz, et al.Expert Review of Anticancer Therapy|October 22, 2013
Clinical practice-changing trials: the HERA study paradigmDimitrios Zardavas, Felipe Ades, Evandro de AzambujaExpert Review of Anticancer Therapy|November 13, 2013
Immunotherapeutic strategies for the treatment of renal cell carcinoma: where are we now?Jens Bedke, Arnulf StenzlExpert Review of Anticancer Therapy|October 25, 2013
Current uses of radiation therapy in patients with primary CNS lymphomaGiovanni Citterio, Andrés José María Ferreri, Michele ReniExpert Review of Anticancer Therapy|September 15, 2015
Rolapitant for the treatment of chemotherapy-induced nausea and vomitingRudolph M NavariExpert Review of Anticancer Therapy|September 18, 2015
Emerging therapeutic approaches in renal cell carcinomaHiral Parekh, Brian I RiniExpert Review of Anticancer Therapy|March 22, 2016
The clinical management of inoperable endometrial carcinomaMarguerite Palisoul, David G MutchExpert Review of Anticancer Therapy|March 25, 2016
Platinum-based chemotherapy in advanced non-small-cell lung cancer: optimal number of treatment cyclesAntonio Rossi, Massimo Di MaioExpert Review of Anticancer Therapy|May 18, 2016
Nicotinamide phosphoribosyltransferase (Nampt) in carcinogenesis: new clinical opportunitiesHang Chen, Shiyu Wang, Haiyuan Zhang, et al.Pageof 310